The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

November 7, 2023

Study Completion Date

November 13, 2023

Conditions

Infertility

Interventions

DRUG

GenSci094

On the morning of day 1 pre-meal, a single SC injection of 150 μg GenSci094 was administered in the abdominal wall.

Trial Locations (1)

Chengdu Xinhua Hospital, affiliated with Sichuan North Medical College, Chengdu

All Listed Sponsors

collaborator

Afﬁliated Hospital of North Sichuan Medical College

OTHER

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT06095206 - The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site | Biotech Hunter | Biotech Hunter